Volume 14, Issue 12, Pages (December 2015)

Slides:



Advertisements
Similar presentations
Volume 370, Issue 9586, Pages (August 2007)
Advertisements

Volume 14, Issue 4, Pages (April 2013)
Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of.
Volume 376, Issue 9747, Pages (October 2010)
Volume 8, Issue 10, Pages (October 2009)
Volume 11, Issue 4, Pages (April 2012)
Volume 388, Issue 10058, Pages (November 2016)
Volume 15, Issue 6, Pages (May 2014)
Volume 378, Issue 9809, Pages (December 2011)
Volume 17, Issue 2, Pages (February 2016)
Volume 388, Issue 10059, Pages (November 2016)
Volume 386, Issue 10008, Pages (November 2015)
Volume 11, Issue 6, Pages (June 2012)
Meta-analysis of randomised controlled trials
Volume 388, Issue 10059, Pages (November 2016)
Volume 5, Issue 4, Pages (April 2006)
Volume 14, Issue 4, Pages (April 2013)
Volume 377, Issue 9783, Pages (June 2011)
Volume 389, Issue 10076, Pages (April 2017)
Volume 7, Issue 8, Pages (August 2008)
Volume 392, Issue 10145, Pages (August 2018)
Volume 387, Issue 10024, Pages (March 2016)
Volume 12, Issue 9, Pages (September 2013)
Volume 12, Issue 9, Pages (September 2013)
Volume 373, Issue 9677, Pages (May 2009)
Volume 376, Issue 9757, Pages (December 2010)
Volume 374, Issue 9707, Pages (December 2009)
Volume 15, Issue 4, Pages (April 2014)
Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled.
Volume 382, Issue 9903, Pages (November 2013)
Volume 15, Issue 4, Pages (April 2014)
Volume 12, Issue 7, Pages (July 2011)
Volume 18, Issue 3, Pages (March 2017)
Volume 379, Issue 9812, Pages (January 2012)
Volume 15, Issue 1, Pages (January 2014)
Volume 11, Issue 3, Pages (March 2012)
Volume 20, Issue 1, Pages (January 2019)
Volume 14, Issue 11, Pages (October 2013)
Volume 381, Issue 9868, Pages (March 2013)
Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled,
Volume 386, Issue 10008, Pages (November 2015)
Volume 19, Issue 4, Pages (April 2018)
Volume 375, Issue 9709, Pages (January 2010)
Volume 371, Issue 9625, Pages (May 2008)
Volume 388, Issue 10058, Pages (November 2016)
A score to predict and stratify risk of tuberculosis in adult contacts of tuberculosis index cases: a prospective derivation and external validation cohort.
Volume 371, Issue 9627, Pages (May 2008)
Volume 378, Issue 9786, Pages (July 2011)
Volume 392, Issue 10162, Pages (December 2018)
Volume 5, Issue 2, Pages (February 2018)
Volume 375, Issue 9726, Pages (May 2010)
Volume 378, Issue 9809, Pages (December 2011)
Volume 373, Issue 9658, Pages (January 2009)
Volume 375, Issue 9719, Pages (March 2010)
Volume 372, Issue 9634, Pages (July 2008)
Volume 15, Issue 6, Pages (May 2014)
Volume 381, Issue 9871, Pages (March 2013)
Volume 376, Issue 9757, Pages (December 2010)
Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: analysis of the population-based Oxford Vascular Study  Sarah.
Volume 375, Issue 9715, Pages (February 2010)
Volume 376, Issue 9747, Pages (October 2010)
Volume 13, Issue 7, Pages (July 2014)
Volume 13, Issue 5, Pages (May 2012)
Volume 12, Issue 1, Pages (January 2011)
Volume 8, Issue 10, Pages (October 2009)
Volume 388, Issue 10042, Pages (July 2016)
Volume 14, Issue 7, Pages (June 2013)
Volume 392, Issue 10162, Pages (December 2018)
Efficacy of live oral rotavirus vaccines by duration of follow-up: a meta-regression of randomised controlled trials  Andrew Clark, PhD, Kevin van Zandvoort,
Volume 17, Issue 2, Pages (February 2016)
Presentation transcript:

Volume 14, Issue 12, Pages 1171-1181 (December 2015) Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analyses  Prof Robert Howard, MD, Rupert McShane, MD, Prof James Lindesay, DM, Craig Ritchie, MD, Ashley Baldwin, FRCPsych, Robert Barber, MD, Prof Alistair Burns, MD, Prof Tom Dening, FRCPsych, David Findlay, FRCPsych, Prof Clive Holmes, FRCPsych, Prof Robert Jones, FRCPsych, Prof Roy Jones, FRCP, Prof Ian McKeith, FMedSci, Ajay Macharouthu, MRCPsych, Prof John O'Brien, DM, Bart Sheehan, MD, Edmund Juszczak, MSc, Prof Cornelius Katona, MD, Prof Robert Hills, DPhil, Prof Martin Knapp, PhD, Prof Clive Ballard, MD, Prof Richard G Brown, PhD, Prof Sube Banerjee, MD, Jessica Adams, BSc, Tony Johnson, PhD, Peter Bentham, MMedSc, Patrick P J Phillips, PhD  The Lancet Neurology  Volume 14, Issue 12, Pages 1171-1181 (December 2015) DOI: 10.1016/S1474-4422(15)00258-6 Copyright © 2015 Elsevier Ltd Terms and Conditions

Figure 1 Trial profile NHP=nursing home placement. SMMSE=Standardised Mini-Mental State Examination. The Lancet Neurology 2015 14, 1171-1181DOI: (10.1016/S1474-4422(15)00258-6) Copyright © 2015 Elsevier Ltd Terms and Conditions

Figure 2 Kaplan-Meier curves of cumulative probability of nursing home placement by (A) treatment group, (B) continuation versus discontinuation of donepezil, and (C) addition of memantine HR=hazard ratio. NHP=nursing home placement. The Lancet Neurology 2015 14, 1171-1181DOI: (10.1016/S1474-4422(15)00258-6) Copyright © 2015 Elsevier Ltd Terms and Conditions

Figure 3 Comparison of the effect of discontinuation with continuation of donepezil on risk of nursing home placement in each category of randomisation minimisation strata and time period from randomisation Data are n (%)/N or event rate ratio (95% CI). Error bars are 95% CIs. The dashed line shows the estimate of the unstratified event rate ratio. The comparison of the effect of memantine is not shown because we noted no overall difference on event rate, stratified or unstratified. SMMSE=Standardised Mini-Mental State Examination. *Difference between observed and expected events within each stratum; this is the log-rank statistic. †All excluding time from randomisation. The Lancet Neurology 2015 14, 1171-1181DOI: (10.1016/S1474-4422(15)00258-6) Copyright © 2015 Elsevier Ltd Terms and Conditions

Figure 4 Change in risk of nursing home placement with time (A) Fitted hazard and (B) cumulative probability of nursing home placement for the flexible parametric survival model. Solid lines show fitted estimates and the dashed lines in (B) show Kaplan-Meier non-parametric estimates. Shaded areas show 95% CIs. This post-hoc analysis shows how the hazard (instantaneous risk) of NHP changes with time. NHP=nursing home placement. The Lancet Neurology 2015 14, 1171-1181DOI: (10.1016/S1474-4422(15)00258-6) Copyright © 2015 Elsevier Ltd Terms and Conditions